Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

Investing.com Gold reports: Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal. Full body text was unavailable at ingest time, so this brief is based on headline context.